Johnson & Johnson (JNJ) Enterprise Value (2009 - 2026)

Johnson & Johnson has disclosed Enterprise Value across 18 years of filings, most recently posting -$22.1 billion for Q1 2026.

• Enterprise Value for Q1 2026 came in at -$22.1 billion, up 43.14% year-over-year; the trailing twelve-month figure through Mar 2026 was -$22.1 billion (up 43.14% YoY), and the FY2025 annual result was -$20.1 billion, up 18.02% from the prior year.
• Enterprise Value came in at -$22.1 billion for Q1 2026 at Johnson & Johnson, down from -$20.1 billion in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$18.6 billion in Q3 2025 to a low of -$38.8 billion in Q1 2025.
• The 5-year median for Enterprise Value is -$24.6 billion (2023), against an average of -$25.8 billion.
• Across the five-year window, Enterprise Value tumbled 47.92% in 2025 and jumped 43.14% in 2026, its largest moves.
• Johnson & Johnson's Enterprise Value stood at -$34.1 billion in 2022, then soared by 32.72% to -$22.9 billion in 2023, then slipped by 6.96% to -$24.5 billion in 2024, then advanced by 18.02% to -$20.1 billion in 2025, then dropped by 9.7% to -$22.1 billion in 2026.
• The last three Enterprise Value figures came in at -$22.1 billion (Q1 2026), -$20.1 billion (Q4 2025), and -$18.6 billion (Q3 2025), per Business Quant data.